NCT04540497 A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04539223 A Study of Evolocumab on Carotid Artery Atherosclerotic Plaque Morphology Prior to Carotid EndArterectomy Status UNKNOWN Phase PHASE4
NCT04528082 Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease Status RECRUITING Phase PHASE3
NCT04524455 Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL Status COMPLETED Phase PHASE1
NCT04521231 A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04511702 Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate Status COMPLETED Phase PHASE4
NCT04506086 Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) Status TERMINATED Phase PHASE4
NCT04483739 Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04478994 A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc) Status TERMINATED Phase PHASE1
NCT04478708 Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity Status COMPLETED Phase PHASE1
NCT04478695 Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia Status TERMINATED Phase PHASE1
NCT04478227 TPO-Mimetic Use in Children for Hematopoietic Failure Status COMPLETED Phase EARLY_PHASE1
NCT04478123 Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer Status COMPLETED Phase PHASE2
NCT04466917 A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer Status WITHDRAWN Phase PHASE3
NCT04448834 Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL Status WITHDRAWN Phase PHASE2
NCT04403698 The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover Status COMPLETED Phase PHASE2